Category : Seaking Alpha

Seeking Alpha / Seaking Alpha - 17 minutes ago

InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

NANJING, China, Nov. 21, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against cancer treatment resistance and metastasis, announced that China National Medical Products Administration (N...

Seeking Alpha / Seaking Alpha - 26 minutes ago

New Report Shows How Much First Jobs Matter

Groundbreaking research from American Student Assistance and Burning Glass Institute studied the careers of millions of workers who went directly to work after high school to identify the Launchpad Jobs that offer the best chances of long-term succes...